Nutraceutical International reports net sales of $47.9M for second-quarter fiscal 2010

NewsGuard 100/100 Score

Nutraceutical International Corporation (Nasdaq: NUTR) today reported results for the fiscal 2010 second quarter ended March 31, 2010.  Net sales for the fiscal 2010 second quarter were $47.9 million compared to $42.0 million for the same quarter of fiscal 2009.  For the second quarter of fiscal 2010, net income was $5.1 million, or $0.49 diluted earnings per share, compared to a net loss of $(23.4) million, or $(2.15) per diluted share, for the same quarter of fiscal 2009.  The second quarter of fiscal 2009 included a non-cash goodwill impairment charge of $37.5 million ($27.3 million after tax, or $2.51 per diluted share).  

Net sales for the six months ended March 31, 2010 were $92.7 million compared to $81.6 million for the same period in fiscal 2009.  For the six months ended March 31, 2010, net income was $9.0 million, or $0.86 per diluted share, compared to a net loss of $(20.2) million, or $(1.86) per diluted share.  The six months ended March 31, 2009 included the $37.5 million non-cash goodwill impairment charge.

Operating cash flow for the six months ended March 31, 2010 was $11.0 million compared to $11.8 million for the same period of fiscal 2009.  This operating cash flow, combined with net borrowings of $12.0 million, was primarily used to invest $8.2 million in purchases of property and equipment, $11.6 million in acquisitions of branded natural product businesses and $2.8 million in repurchases of common stock.  

Bill Gay, chairman and chief executive officer, commented, "Our overall business continues to improve as Health and Natural Food Store consumers seek a broader selection of products, not offered in other channels, to help maintain their healthy lifestyle.  Traditionally our second quarter is usually our best overall financial quarter of the fiscal year and this was no exception.  Net sales of domestic and international branded products grew during the quarter primarily as a result of integrating our most recent acquisitions. Our quarterly increase in net income and Adjusted EBITDA was primarily generated by leveraging our selling, general and administrative expenses."

Mr. Gay continued, "This quarter's financial results were extremely encouraging in light of the fact that several historically strong regional US markets remained less vibrant than the overall national market.  Most areas of the country are steadily improving for us and the economic cloud of uncertainty is diminishing for our health conscious consumer.  It appears that Health and Natural Food consumers continue to keep their focus on making healthy lifestyle choices during stressful times.   In any case, we are continuing to invest in and automate additional areas of the company with a strong focus on distribution and manufacturing processes to allow for future growth and expansion.  We will focus on finding additional efficiencies and cutting our controllable costs as we identify and make new acquisitions.  We appreciate every customer, employee and shareholder for the ongoing support they provide us in allowing us to execute our long-term business strategy and we look forward to a successful fiscal 2010."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Food additive emulsifiers linked to increased risk of type 2 diabetes